✦ LIBER ✦

Anti-inflammatory drugs and tumor necrosis factor-α production from monocytes: role of transcription factor NF-κB and implication for rheumatoid arthritis therapy

✍ Scribed by Luisa Lavagno; Gabriele Gunella; Claudio Bardelli; Simona Spina; Luigia Grazia Fresu; Ilario Viano; Sandra Brunelleschi

Book ID: 113584960
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 340 KB
Volume: 501
Category: Article
ISSN: 0014-2999
DOI: 10.1016/j.ejphar.2004.07.101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF-κB–regulated expression of cellular F

NF-κB–regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor α–mediated apoptosis

✍ Shaochun Bai; Hongtao Liu; Kun-Hung Chen; Polikseni Eksarko; Harris Perlman; Ter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Induction of tumor necrosis factor α pro

Induction of tumor necrosis factor α production by adhered human monocytes: A key role for Fcγ receptor type IIIA in rheumatoid arthritis

✍ Vikki M. Abrahams; Geraldine Cambridge; Peter M. Lydyard; Jonathan C. W. Edwards 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB 👁 1 views

Blocking of interferon regulatory factor

Blocking of interferon regulatory factor 1 reduces tumor necrosis factor α–induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein a: Role of the nuclear interferon regulatory factor 1–NF-κB–c-jun complex

✍ Hubert Marotte; Pei-Suen Tsou; Bradley J. Rabquer; Adam J. Pinney; Tatiana Fedor 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

## Abstract ## Objective To examine the role of interferon regulatory factor 1 (IRF‐1) in tumor necrosis factor α (TNFα)–induced interleukin‐18 binding protein a (IL‐18BPa) expression in rheumatoid arthritis synovial fibroblasts (RASFs). ## Methods TNFα‐induced IRF‐1 expression was assessed by r

Reduction in the incidence of myocardial

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

✍ W. G. Dixon; K. D. Watson; M. Lunt; K. L. Hyrich; A. J. Silman; D. P. M. Symmons 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Surface-bound anti–type II collagen–cont

Surface-bound anti–type II collagen–containing immune complexes induce production of tumor necrosis factor α, interleukin-1β, and interleukin-8 from peripheral blood monocytes via fcγ receptor IIA: A potential pathophysiologic mechanism for humoral anti–type II collagen immunity in arthritis

✍ Mohammed Mullazehi; Linda Mathsson; Jon Lampa; Johan Rönnelid 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views